Human Epidermal Growth Factor Receptor 2 (HER2) as Surrogate Prognostic Marker in Gastric and Gastro Esophageal Junction Cancer

Human Epidermal Growth Factor Receptor 2 (HER2) as Surrogate Prognostic Marker in Gastric and Gastro Esophageal Junction Cancer

Background: HER2 is an important biomarker in gastric and gastroesophageal junction tumors. Expression of HER2 status by immunohistochemistry is heterogeneous in various patient populations. This overexpression appears to be an important prognostic factor in gastric cancer and its association with o...

Full description

Bibliographic Details
Main Authors: Shareefa Akhter, Nassima Chanda, Rumana Hamid, Malik Tariq Rasool
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:MRIMS Journal of Health Sciences
Subjects:
gastric carcinoma
her2
pathological characteristics
immunohistochemistry
surrogate marker
Online Access:http://www.mrimsjournal.com/article.asp?issn=2321-7006;year=2019;volume=7;issue=2;spage=53;epage=58;aulast=Akhter;type=0

Similar Items

Similar Items